Figure 3From: Uncovering the cathepsin system in heart failure patients submitted to Left Ventricular Assist Device (LVAD) implantation Serine cathepsin system. mRNA expression of serine cathepsin system in cardiac tissue from ESHF patients of pre-LVAD group (n = 22), HT control group (n = 35) and post-LVAD group (n = 30), respectively. Relative expressions (mean value ± SEM) of CatG (A) and SrpA3 (B) are shown.Back to article page